WENDY STRAITWELL: Open Payments
NPI 1588041495 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,744 in 100 payments from 22 companies in 2025. Trend: 2023 $1,569 · 2024 $1,498 · 2025 $1,744
Food & beverage: $1,744
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $311 |
| Novo Nordisk Inc | 11 | $194 |
| Amgen Inc. | 14 | $188 |
| PFIZER INC. | 8 | $176 |
| GlaxoSmithKline, LLC. | 18 | $152 |
| Astellas Pharma US Inc | 5 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $108 |
| SANOFI-AVENTIS U.S. LLC | 2 | $75 |
| Esperion Therapeutics, Inc. | 4 | $73 |
| IBSA Pharma Inc. | 2 | $44 |
Products named: QULIPTA, NURTEC ODT, Veozah, TRELEGY ELLIPTA, CAPLYTA, Ozempic, EVENITY, TZIELD.
Industry payments across FL — which companies pay providers there.
